• Biodefense; Biomedical Advanced Research and Development Authority funding; vaccine research, development, manufacturing and marketing; infectious diseases; PAHPA; Labor-HHS-ED appropriations bills; NDAA

Duration: November 1, 2007 to September 11, 2017

General Issues: Pharmacy, Health Issues, Medical/Disease Research/Clinical Labs, Defense, Disaster Planning/Emergencies, Homeland Security, Science/Technology, Budget/Appropriations, Trade (Domestic & Foreign)

Spending: about $8,925,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2007: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS), Executive Office of the President (EOP), Defense Threat Reduction Agency (DTRA)

Related Foreign Entities: Bavarian Nordic A/S (Kvistgard, DEN); contribution to lobbying: $200000; ownership 100%; Bavarian Nordic A/S (DK-3490 , DEN); contribution to lobbying: $0; ownership 100%; Bavarian Nordic A/S (DK3490 Kvistgaard, DEN); contribution to lobbying: $200000; ownership 100%